IntriCon Corporation (IIN): Price and Financial Metrics


IntriCon Corporation (IIN): $24.32

-0.98 (-3.87%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

IIN Stock Summary

  • IIN's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 238.27 -- higher than 84.67% of US-listed equities with positive expected earnings growth.
  • Intricon Corp's stock had its IPO on January 1, 1986, making it an older stock than 92.8% of US equities in our set.
  • Price to trailing twelve month operating cash flow for IIN is currently 40.54, higher than 87.84% of US stocks with positive operating cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Intricon Corp are TRUE, XXII, OBLN, SNES, and CSII.
  • IIN's SEC filings can be seen here. And to visit Intricon Corp's official web site, go to www.intricon.com.

IIN Stock Price Chart Interactive Chart >

Price chart for IIN

IIN Price/Volume Stats

Current price $24.32 52-week high $28.16
Prev. close $25.30 52-week low $9.95
Day low $24.32 Volume 52,639
Day high $25.79 Avg. volume 45,566
50-day MA $24.49 Dividend yield N/A
200-day MA $17.11 Market Cap 218.83M

IntriCon Corporation (IIN) Company Bio


IntriCon Corporation designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets. The company also provides medical and micro coils for pacemaker programming and interventional catheter positioning applications; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear-and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. IntriCon Corporation was formerly known as Selas Corporation of America. The company was founded in 1930 and is based in Arden Hills, Minnesota.

IIN Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$24.32$3.03 -88%

We started the process of determining a valid price forecast for Intricon Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Intricon Corp ranked in the 15th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 88%. In terms of the factors that were most noteworthy in this DCF analysis for IIN, they are:

  • The business' balance sheet reveals debt to be 3% of the company's capital (with equity being the remaining amount). Approximately merely 12.91% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • As a business, Intricon Corp experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than only 0% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-88%
1%-88%
2%-88%
3%-88%
4%-88%
5%-88%

Want more companies with a valuation profile/forecast similar to that of Intricon Corp? See BHC, LCI, MD, PAHC, and TECH.


IIN Latest News Stream


Event/Time News Detail
Loading, please wait...

IIN Latest Social Stream


Loading social stream, please wait...

View Full IIN Social Stream

Latest IIN News From Around the Web

Below are the latest news stories about Intricon Corp that investors may wish to consider to help them evaluate IIN as an investment opportunity.

Intricon Appoints Kathleen Pepski to its Board of Directors

ARDEN HILLS, Minn., March 22, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable and body-worn medical devices, today announced the appointment of Kathleen Pepski to the company’s Board of Directors, effective March 19, 2021. “We are delighted to welcome Kathleen to Intricon and our board of directors,” said Scott Longval, President and Chief Executive Officer of Intricon. “Kathleen is a well-respected business leader in Minneapolis whose background in manufacturing and distribution, as well as mergers and acquisitions, will be instrumental in our long-term growth strategy.” Ms. Pepski’s career includes more than 30 years of finance and accounting exp...

Yahoo | March 22, 2021

Europe Ear-Based Hearing Aids Market 2028 Competitions by Players, Present Situation Analysis, Development, Challenges | GN Store Nord A/S, IntriCon Corporation, MED-EL, Sivantos Pte. Ltd., Sonova, Starkey, Knowles Electronics

Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Europe Ear-Based Hearing Aids Market : Global Opportunity Analysis and Industry Forecast 2021-2028’. The Europe Ear-Based Hearing Aids Market is expected to witness growth in upcoming years due to factors such

OpenPR | March 3, 2021

Intricon to Announce 2020 Fourth Quarter and Full Year Results on Thursday, February 25, 2021

ARDEN HILLS, Minn., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 fourth quarter and full year results on Thursday, February 25, 2021, after market close. Following the release, Intricon’s management team will host a conference call on the same day, beginning at 4:00 p.m. CT/5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (866) 795-7248 for domestic callers or (470) 495-9160 for international callers, using conference ID: 5468087. A live and archived webcast will be available on the “Investors” sections of the company’s...

Yahoo | February 11, 2021

What Type Of Shareholders Own The Most Number of IntriCon Corporation (NASDAQ:IIN) Shares?

The big shareholder groups in IntriCon Corporation ( NASDAQ:IIN ) have power over the company. Large companies usually...

Yahoo | February 10, 2021

Royce & Associates increased stake in IntriCon Corporation

https://www.investing.com/news/stock-market-news/royce--associates-increased-stake-in-intricon-corporation-2400594

Investing.com | January 27, 2021

Read More 'IIN' Stories Here

IIN Price Returns

1-mo 6.29%
3-mo 18.35%
6-mo 86.65%
1-year 125.39%
3-year 4.83%
5-year 282.99%
YTD 34.36%
2020 0.56%
2019 -31.77%
2018 33.23%
2017 186.96%
2016 -8.97%

Continue Researching IIN

Here are a few links from around the web to help you further your research on Intricon Corp's stock as an investment opportunity:

Intricon Corp (IIN) Stock Price | Nasdaq
Intricon Corp (IIN) Stock Quote, History and News - Yahoo Finance
Intricon Corp (IIN) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.243 seconds.